People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Other, Software / Tech, Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sustainable Bioproducts, Inc. | — | Other | Series D+ | $460.0M | $5.3B | 2020 |
| Turntide Technologies Inc. | — | Software / Tech | Series C | $171.2M | $2.2B | 2020 |
| Nobell Foods, Inc. | — | Biotechnology | Series C | $102.4M | $2.1B | 2019 |
| Graphyte, Inc. | — | Other | Series B | $37.8M | $229.3M | 2024 |
| Arkea Bio Corp. | — | Biotech / Pharma | Series A | $7.0M | $20.5M | 2025 |
Chris Rivest at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Rivest on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Vijay Pande | 1 | 9 |
| Shvetank Jain | 1 | 7 |
| Kyle Vogt | 1 | 5 |
| Matthew Eggers | 1 | 4 |
| Andrew Chung | 1 | 4 |
| Sergey Polikarpov | 1 | 3 |
| Mark Johnston | 1 | 3 |
| Greg Smithies | 1 | 3 |
| Richard Linder | 1 | 3 |
| Zachariah Serber | 1 | 2 |
| Nilesh Patel | 1 | 2 |
| Kim Kolt | 1 | 2 |
| Lila Preston | 1 | 2 |
| Ryan Morris | 1 | 2 |
| Frank Wooten | 1 | 2 |
| John Bannon | 1 | 1 |
| Robert Flohr | 1 | 1 |
| Shventank Jain | 1 | 1 |
| Wayne McNee | 1 | 1 |
| Barclay Rogers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.